OmniAb, Inc. (OABI) Deep Dive Video
Summary
OmniAb (OABI) offers an asymmetric platform-biotech setup: a debt-free antibody discovery royalty engine with rising partner momentum, upgraded 2026 guidance, and substantial upside if late-stage partner assets convert into commercial royalties.
View OABI stock page · Read the OABI research report
Loading the video player…